Investing.com - OptiNose reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
OptiNose announced earnings per share of $-0.180 on revenue of $20.1M. Analysts polled by Investing.com anticipated EPS of $-0.190 on revenue of $23.55M.
OptiNose shares are down 24% from the beginning of the year, still down 24.42% from its 52 week high of $4.30 set on August 17.
OptiNose shares lost 7.69% in pre-market trade following the report.
OptiNose follows other major Healthcare sector earnings this month
OptiNose's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar